Zhizhong Ye

Zhizhong Ye


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
GYGuiwen Ye
Guiwen Ye
ZXZhongyu Xie
Zhongyu Xie
HZHuiqiong Zeng
Huiqiong Zeng
PWPeng Wang
Peng Wang
JLJinteng Li
Jinteng Li
SHShen Huiyong
Shen Huiyong
Ankylosing spondylitis (AS) is a chronic inflammatory disease possessing a morbid serum microenvironment with enhanced oxidative stress. Long-term exposure to an oxidative environment usually results in cellular senescence alone with cellular dysfunction. Mesenchymal stem cells (MSCs) are a kind of stem cell possessing strong capabilities for immunoregulation, and senescent MSCs may increase inflammation and participate in AS pathogenesis. The objective of this study was to explore whether and how the oxidative serum environment of AS induces MSC senescence. Here, we found that AS serum facilitated senescence of MSCs in vitro, and articular tissues from AS patients exhibited higher expression levels of the cell cycle arrest-related proteins p53, p21 and p16. Importantly, the levels of advanced oxidative protein products (AOPPs), markers of oxidative stress, were increased in AS serum and positively correlated with the extent of MSC senescence induced by AS serum. Furthermore, MSCs cultured with AS serum showed decreased mitochondrial membrane potential and ATP production together with a reduced oxygen consumption rate. Finally, we discovered that AS serum-induced mitochondrial dysfunction resulted in elevated reactive oxygen species (ROS) in MSCs, and ROS inhibition successfully rescued MSCs from senescence. In conclusion, our data demonstrated that the oxidative serum environment of AS facilitated MSC senescence through inducing mitochondrial dysfunction and excessive ROS production. These results may help elucidate the pathogenesis of AS and provide potential targets for AS treatment.

15 August 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YMYao Meng
Yao Meng
JMJianyang Ma
Jianyang Ma
CYChao Yao
Chao Yao
ZYZhizhong Ye
Zhizhong Ye
HDHuihua Ding
Huihua Ding
NSNan Shen
Nan Shen
Plasmacytoid dendritic cells (pDCs) are a professional type I IFN producer that play critical roles in the pathogenesis of autoimmune diseases. However, both genetic regulation of the function of pDCs and their relationships with autoimmunity are largely undetermined. Here, we investigated the causality of the neutrophil cytosolic factor 1 (NCF1) missense variant, which is one of the most significant associated risk variants for lupus, and found that the substitution of arginine (R) for histidine (H) at position 90 in the NCF1 protein (NCF1 p.R90H) led to excessive activation of pDCs. A mechanism study demonstrated that p.R90H reduced the affinity of NCF1 for phospholipids, thereby impairing endosomal localization of NCF1. As NCF1 is a subunit of the NADPH oxidase 2 (NOX2) complex, this impairment led to an acidified endosomal pH and facilitated downstream TLR signaling. Consistently, the homozygous knockin mice manifested aggravated lupus progression in a pDC-dependent lupus model. More important, pharmaceutical intervention revealed that hydroxychloroquine (HCQ) could antagonize the detrimental function of NCF1 p.R90H in the lupus model and systemic lupus erythematosus samples, supporting the idea that NCF1 p.R90H could be identified as a genetic biomarker for HCQ application. Therefore, our study provides insights into the genetic control of pDC function and a paradigm for applying genetic variants to improve targeted therapy for autoimmune diseases.

1 July 2020 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
JLJun Li
Jun Li
HDHuihua Ding
Huihua Ding
YMYao Meng
Yao Meng
GLGuanhua Li
Guanhua Li
QFQiong Fu
Qiong Fu
NSNan Shen
Nan Shen

3 September 2019 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JZJing Zeng
Jing Zeng
XMXinyu Meng
Xinyu Meng
PZPing Zhou
Ping Zhou
ZYZhihua Yin
Zhihua Yin
QXQinglian Xie
Qinglian Xie
YTYuanjia Tang
Yuanjia Tang
Neuropsychiatric systemic lupus erythaematosus (NP-SLE) is one of the major manifestations of lupus. However, the mechanisms involved in NP-SLE are still largely unknown. The abnormal activation of the type I IFN signalling pathway is involved in SLE pathogenesis and is linked to NP-SLE, but the effect of IFN-α on NP-SLE encephalopathy has not been systematically studied. An intravenous injection of Adv-IFN-α (10 mice, 10 × 109 vp) was administered to the IFN-α-treated group, and Adv-ctrl (10 mice, 10 × 109 vp) (ViGene Biosciences, China) was administered to the control group. Gene expression was determined by real-time quantitative polymerase chain reaction (RT-qPCR). Enzyme-linked immunosorbent assay (ELISA) was used to detect antibodies in the serum, and urinary protein levels were measured with a BCA Protein Assay kit. Haematoxylin-eosin (H&E) and periodic acid-Schiff (PAS)-light green staining were used for kidney histology. The elevated plus-maze test, novelty-suppressed feeding assay, open-field test, tail suspension test, social dominance tube test, three-chamber social interaction test, step-down passive avoidance test and novelty Y-maze task were used to assess behaviour. In this study, we performed a series of behavioural tests to assess the neuropsychiatric phenotypes of IFN-α-treated NZB/NZW F1 mice and found that these mice developed a series of mental disorders such as anxiety-like phenotypes, depression-like phenotypes, deficits in sociability and cognitive impairments, which mimic the neuropsychiatric manifestations of NP-SLE, with a consistent onset and progression. Our research verified that IFN-α plays a critical role in NP-SLE and provides a comprehensive NP-SLE mouse model for dissecting the mechanisms of NP-SLE and developing novel therapies for intervention.

1 August 2021 in Tissue and Cell
Verified
Journal Article
Closed access
GLGuanhua Li
Guanhua Li
LLLu Liu
Lu Liu
ZYZhizhong Ye
Zhizhong Ye
ZYZhizhong Ye
Zhizhong Ye
NSNan Shen
Nan Shen

9 June 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
LSLitao Shao
Litao Shao
LDLu Ding
Lu Ding
WLWeizhao Li
Weizhao Li
CZChi Zhang
Chi Zhang
YXYu Xia
Yu Xia
DDDavid Y.B. Deng
David Y.B. Deng
Osteoarthritis (OA) is a prevalent degenerative joint disorder affecting over 240 million people worldwide, yet no disease-modifying therapies currently exist, with clinical management limited to symptomatic relief or joint replacement. Exosomes (Exos) from bone marrow mesenchymal stem cells (ExoBMSC) play positive role in the treatment of cartilage damage. Parathyroid hormone (PTH) (1–34) can enhance cartilage repair. Here, We found Exos from ExoBMSC reduces cartilage damage during treatment. Meanwhile, the Exos of PTH(1–34)-preconditioned BMSCs (ExoPTH) can alleviate OA better than ExoBMSC. Through MicroRNA (miRNA) sequencing analysis, this study aims to reveal the effects and potential mechanism of miRNA (let-7a-5p) in ExoPTH to repair OA cartilage. Differential centrifugation was used for isolating ExoBMSC and ExoPTH. Extract bone marrow mesenchymal stem cells from rats and utilize the C28/I2 chondrocytes line, the OA model was established using lipopolysaccharide (LPS; 1 µg/mL) in vitro. OA was induced in rats with intra-articular injection with collagenase-2. By performing a miRNA array, RNA-seq, in addition to bioinformatic analysis, the miRNA and the potential regulatory mechanism were detected. We compared in vitro let-7a-5p effects on the ability of OA chondrocytes to proliferate, migrate, apoptosis, and form the extracellular matrix (ECM). Histological and immunohistochemical assessments were used for evaluating cartilage pathology in vivo. We extracted ExoBMSC and ExoPTH and established the OA model in vitro. Compared with ExoBMSC group, ExoPTH group has a stronger effect on promoting the proliferation and migration of chondrocytes. ExoBMSC and ExoPTH can inhibit the apoptosis of chondrocytes, but there was no significant difference between the two groups. The two most significant differences in groups ExoBMSC and ExoPTH are let-7a-5p. Let-7a-5p promotes OA chondrocytes proliferation and migration by inhibiting the expression of IL-6 in vitro experiments. For in vivo experiments, let-7a-5p delays the progression of OA. Our study shows that ExoPTH may improve the regulatory inflammatory responses to delays the progression of OA by shuttling let-7a-5p. Let-7a-5p promoted chondrocytes migration and proliferation to suppress OA pathology by inhibiting IL-6/STAT3 pathway.